ArticleRheumatology advances in practice2019

Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry.

Christos G Papadopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.